May 16, 2016
Injections of the soil bacterium Mycobacterium vaccae promote stress resilience and improve coping behaviors in mice, according to a new study led by researchers at University of California San Diego School of Medicine and University of Colorado Boulder. The researchers also found that
April 11, 2019
Treatment with a choline kinase inhibitor prompts immune cells to clear away damaged mitochondria, thus reducing NLRP3 inflammasome activation and preventing inflammation
April 6, 2020
UC San Diego Health makes measurable progress addressing COVID-19 testing shortage through multiple partnerships and rapidly growing in-house testing. Success has meant more testing for more patients, first responders and other health systems.
July 23, 2020
…into quarantine knowing my immune system was bad,” said Circo. “When the pandemic hit, I wasn’t worried about contracting COVID because I saw that Moores Cancer Center took quick action. Patients and employees were wearing face masks and visitors restrictions were put in place. I had peace of mind knowing…
January 10, 2013
A team of surgeons and scientists at University of California, San Diego School of Medicine have developed a new technique that will allow surgeons to identify during surgery which lymph nodes are cancerous so that healthy tissue can be saved. The findings will be published in the January 15 print…
April 29, 2020
UC San Diego Health has launched a Phase III clinical trial to assess whether a medication used to treat rheumatoid might also have therapeutic value for patient with COVID-19 who have developed or are at high risk of developing serious lung damage from SARS-CoV-2 infections.
April 3, 2023
Three faculty members at the University of California San Diego were inducted into the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE). Professors Victor Nizet, Karsten Zengler and Sameer Shah are among the 140 new AIMBE Fellows in the class of 2023. In ad
October 21, 2020
San Diego-based Cellics Therapeutics, which was co-founded by UC San Diego nanoengineering Professor Liangfang Zhang, has received an award of up to $15M to develop a macrophage cellular nanosponge—nanoparticles cloaked in the cell membranes of macrophages—designed to treat sepsis.
April 11, 2024
Researchers from UC San Diego have discovered the biochemical workings of an old-fashioned diabetes drug, and it’s helping them develop new, safer alternatives.
January 26, 2022
Six researchers and leaders at the University of California San Diego have been named Fellows of the American Association for the Advancement of Science (AAAS), the largest general science organization in the world and publisher of the journal Science.
